1. Anti-infection
  2. Bacterial
  3. Mucinase StcE

Mucinase StcE is a zinc metalloproteinase belonging to the M66 family, which is secreted by enterohemorrhagic Escherichia coli via the type II general secretion pathway. Mucinase StcE specifically recognizes and cleaves the 'T*XT' motif in mucin-type glycoproteins with α-O-glycans (such as MUC2, Mucin 7, Glycoprotein 340, CD45, CD43, C1 Esterase Inhibitor (HY-P991629), etc.). By degrading the mucus layer to reduce its viscosity, inhibiting complement cascade activation, and localizing complement regulatory factors to the cell membrane, Mucinase StcE helps bacteria penetrate the mucosal barrier, adhere to host cells, and evade immune clearance. Mucinase StcE can serve as a mucin-specific proteolytic tool for research on mucinous carcinomas derived from the colon, esophagus, and salivary glands.

For research use only. We do not sell to patients.

Mucinase StcE

Mucinase StcE Chemical Structure

Size Price Stock Quantity
100 μg In-stock

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Mucinase StcE is a zinc metalloproteinase belonging to the M66 family, which is secreted by enterohemorrhagic Escherichia coli via the type II general secretion pathway. Mucinase StcE specifically recognizes and cleaves the 'T*XT' motif in mucin-type glycoproteins with α-O-glycans (such as MUC2, Mucin 7, Glycoprotein 340, CD45, CD43, C1 Esterase Inhibitor (HY-P991629), etc.). By degrading the mucus layer to reduce its viscosity, inhibiting complement cascade activation, and localizing complement regulatory factors to the cell membrane, Mucinase StcE helps bacteria penetrate the mucosal barrier, adhere to host cells, and evade immune clearance. Mucinase StcE can serve as a mucin-specific proteolytic tool for research on mucinous carcinomas derived from the colon, esophagus, and salivary glands[1][2].

In Vitro

Mucinase StcE (0.5-1 mg/mL) exists as a monomer in solution and forms a 1:1 complex with its substrate C1 Esterase Inhibitor (HY-P991629)[1].
Mucinase StcE (overnight; 37 °C) enables tissue enzymatic digestion, and spatial visualization of different MUC2 glycoforms and tumor-specific O-glycopeptides in mucinous carcinoma tissues is achieved via MALDI-MSI[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Mucinase StcE (0.1 μg/μL, 0.05 mg/mL; overnight (13-23 hours); 37°C) reveals the tumor-specific spatial segregation of MUC2 glycoforms modified by Tn and T antigens in human colorectal mucinous adenocarcinoma samples[2].
Mucinase StcE (0.1 μg/μL, 0.05 mg/mL; overnight (13-23 hour); 37°C) enables spatial localization and glycoproteomic identification of T-antigen-dominant versican glycoforms in human salivary gland mucoepidermoid carcinoma specimens[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: archival formalin-fixed, paraffin-embedded tissue specimens (mucinous carcinoma patients)[2]
Dosage: 0.1 µg/µL (sprayer-applied); 0.05 mg/mL (pipette-applied to tumor regions)
Administration: on-slide; overnight (13-23 hour) incubation at 37°C (for 0.05 mg/mL dose); one set of 15 passes (for 0.1 µg/µL dose)
Result: Enabled spatial mapping of MUC2 O-glycopeptides via MALDI-MSI, revealing distinct distribution patterns: Tn-only MUC2 glycopeptides clustered in specific tumor regions adjacent to fibrotic or non-mucinous malignant tissue, while glycoforms with both T and Tn antigens were diffusely distributed across the mucinous tumor, and T-only glycoforms localized near the tumor edge adjacent to adipose tissue.
Yielded 91.2% sequence coverage over the two PTS domains of MUC2 via LC-MS, with most localized O-glycans being Tn or T antigens; low-abundance core 2 structures, mono- and di-O-acetylated sialic acid-containing glycans, and a putative O-acetylated GalNAc modification were also identified.
Restricted StcE-derived O-glycopeptides exclusively within tumor boundaries.\nRevealed via MALDI-MSI that Tn-only MUC2 glycopeptides concentrated at a single tumor site bordering non-mucinous adenocarcinoma tissue, while T antigen-containing glycoforms spread over a larger portion of the tumor region.
Confirmed 91.2% sequence coverage over MUC2's two PTS domains via LC-MS, with dominant Tn and T antigen modifications, plus low-abundance modified glycans including di-O-acetylated sialic acid and putative O-acetylated GalNAc.
Restricted StcE-derived O-glycopeptides to tumor boundaries.
Animal Model: archival formalin-fixed, paraffin-embedded tissue specimens (mucinous carcinoma patients)[2]
Dosage: 0.1 µg/µL (sprayer-applied); 0.05 mg/mL (pipette-applied to tumor regions)
Administration: on-slide; overnight (13-23 hour) incubation at 37°C (for 0.05 mg/mL dose); one set of 15 passes (for 0.1 µg/µL dose)
Result: Detected StcE-generated glycopeptides diffusely distributed across the tumor, with some spillover into adjacent parotid tissue via MALDI-MSI.
Revealed via LC-MS that glycopeptide results were dominated by versican, with core 1 and core 2 structures (with and without sialylation) localized on versican glycopeptides; most were decorated exclusively with T antigens, with very few Tn antigen-modified species.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Mucinase StcE]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Mucinase StcE
Cat. No.:
HY-E70562
Quantity:
MCE Japan Authorized Agent: